📢 SIGN & SHARE THE PETITION! 📢 New York needs an Empire Biomedical Research Institute to create new statewide funding opportunities for scientists & physician-scientists so that patients and their families get the life-saving and life-changing new therapeutics they're hoping for ✏️ c.org/TDMy2H9JTW

Check out our highlight of an exciting new preprint by Dr. Claudia Rivera from Dr. Yasmine Belkaid's group 👇

Interesting study from the ppl @solvingforsci.bsky.social. Very much in line with our earlier findings with @preprintclub.bsky.social (www.biorxiv.org/content/10.1...) : 1/ Reviewers can distinguish quality and impact (+novelty in our model) 2/ Trainees want to review 3/ Authors love the experience

Very exciting to finally see clinical data where viral mimicry provides survival benefits

Short, noncoding YRNA can activate pathological variants of the innate sensor RIG-I, causing autoinflammation and #lupus nephritis in mouse models. Learn more in #ScienceImmunology: https://scim.ag/43ewTiV

It was a great experience to present our latest work on cancer vaccines in front of an audience of TE experts

Proud of our Yu-Chan Chih for receiving the Trainee Innovation Idea Award for his work on cancer vaccination 👏🥇

Y RNAs getting some of the recognition they deserve

Check out our latest in @cp-trendscancer.bsky.social where rockstar PhD student @laurarosenberg.bsky.social reviews cancer therapies known to induce innate immune responses through the reactivation of Transposable Elements.

Check out our review on the role of #retroelements and #viralmimicry during cancer treatment! @neoviral.bsky.social

America’s cancer research system is under threat in one of its most productive moments. www.nytimes.com/2025/09/14/m...

The Empire State can’t afford to fall behind. A group of scientists is launching NY-CURES to fight for state and city level investment in research.✊ 📢 Sign up & show Albany we stand UNITED for science. 👉 www.nycures.org @miriammerad.bsky.social @bogunoviclab.bsky.social #AdvocateForScience #NYCURES

🚀 NY-CURES Launch — Championing State-Wide Investment in Science! 🚀 Our new coalition advocates for sustained public support of New York’s vibrant biomedical research ecosystem — creating cures, economic gains & strengthening communities. Sign up. Stay informed. Join the movement: www.nycures.org/

Latest from us: we detail the protocol we use to generate mRNA-LNPs and to study immune response in preclinical setting. link.springer.com/protocol/10....

🎉 Congrats to student extraordinaire @bhavyasighs.bsky.social who earned a scholarship from #CIHR AND got a paper accepted in the same week!

Another nice example of a host-acquired gene in poxviruses, which modulates the host immune response. dx.plos.org/10.1371/jour...

More great content from @preprintclub.bsky.social @epelmanlab.bsky.social. This @biorxiv-immuno.bsky.social preprint from Liu et al. reports that resident tissue macrophages in the conventional outflow tract regulate intraocular pressure.

Scientists Say NIH Officials Told Them To Scrub mRNA References on Grants kffhealthnews.org/news/article...

NIH to ax grants on vaccine hesitancy, mRNA vaccines www.science.org/content/arti...

Who funds biomedical research? @nature.com www.nature.com/articles/d41...

Absolutely stellar presentations by Brian Brown, Rafi Ahmed, Michel Sadelain and Craig Crews happening now for day 1 of our immunoschool.

NYC #standupforscience

Join us tomorrow, March 7th, at Washington Square Park! US Science is under unprecedented attack. Science saves lives, drives innovation and progress. Stand Up for Science, Stand Up for America. #standupforscience2025

🚨 Last days to register to next week #Immunoschool! Don't miss out! 👇 t.co/nsPLcdX3wT

At next week's 🎓 Immunoschool 🎓, Dan Littman discovered how the microbiota shapes immune responses & the role of Th17 cells in autoimmunity. Register to hear about microbiota-immune interactions that influence immunotherapy, driving novel therapeutic strategies >>> www.eventbrite.com/e/internatio...

Don't forget to sign up for International ImmunoSchool, a FREE online course held on March 10–12! Learn from leaders in immunotherapy about the latest advancements in the field. 🔗 Register now: www.immunoschool.org

Nature Story "Revealed: NIH research grants still frozen despite lawsuits challenging Trump order" (with non-paywalled link) archive.ph/7h6Im

Registration is now open for the next ImmunoSchool! This year’s theme: "10 Years of Discovery in Immunotherapy." We’ve put together a stellar lineup of speakers—don’t miss it! Free registration @ bit.ly/3WFj0Hc #ImmunoSchool #Immunotherapy #CancerResearch

Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen www.nature.com/articles/s41... @lukasbunse.bsky.social @naturecomms.bsky.social

Very proud of my Ph.D student Ashley who brilliantly defended her thesis last Friday!

Call for entries 📣 The international €350K #EinsteinFoundationAward honors researchers and institutions across all scientific disciplines working to advance #research quality. Deadline: 30 April 2025 - please share! 🌍 (1/2) ➡️ award.einsteinfoundation.de #OpenScience #reproducibility

We wanted to remind you that you can read our preprint feedback under the “Community reviews” button on @biorxivpreprint.bsky.social 😊

It’s crazy how talking with a science buddy is simultaneously what’s most likely to move the project forward and the thing that’s least prioritized in our schedule.

Beautiful and potentially very impactful.

#PreprintClub is now on Bluesky! Who are we and what are we doing? We are a group of enthusiastic scientists that gather together once a week to discuss fresh preprints in the field of #immunology. 🦠🧬

Alternative #publishing: You post a #preprint, others read-comment-evaluate, journal highlights (positively) evaluated preprint. Interesting example: coordinated evaluation by #PreprintClub and highlighting by @natrevimmunol.bsky.social www.nature.com/articles/s41...